Reynolds Cameron John

Average Profitability
12.08%
Insider Buys Quantity
8
Insider Buys Sum
$110,780.90
Insider Sells Quantity
2
Insider Sells Sum
$24,001.20

Insider Activity of Reynolds Cameron John

According to the SEC Form 4 filings, Reynolds Cameron John, being in a position of

  1. President and CEO at VolitionRx Limited,
    оver the last 12 months, has bought 10000 shares for $6,700, and sold 0 shares,
    over all time since 2014-09-03, has bought 56960 shares for $110,781, and sold 2082780 shares for $24,001.

The largest purchase of all time was on 2018-08-16 and amounted to 13000 shares of VolitionRx Limited for $24,830.

The largest sale of all time was on 2016-05-20 and amounted to 6780 shares of VolitionRx Limited for $24,001.

Biography of Reynolds Cameron John

No biography is available at this moment.

2023-12-08PurchaseVolitionRx Limited
VNRX
President and CEO
10,000
0.0131%
$0.67$6,700+12.73%
2023-08-16PurchaseVolitionRx Limited
VNRX
President and CEO
10,000
0.0135%
$1.22$12,200-35%
2022-08-30PurchaseVolitionRx Limited
VNRX
President and CEO
3,500
0.006%
$1.61$5,635+3.01%
2020-05-22PurchaseVolitionRx Limited
VNRX
President and CEO
8,000
0.0169%
$2.75$22,000+15.67%
2019-12-05PurchaseVolitionRx Limited
VNRX
President and CEO
2,200
0.0053%
$4.24$9,328-18.22%
2018-08-16PurchaseVolitionRx Limited
VNRX
President and CEO
13,000
0.0437%
$1.91$24,830+67.63%
2017-08-16PurchaseVolitionRx Limited
VNRX
President and CEO
7,260
0.0295%
$2.77$20,110-4.47%
2016-05-20SaleVolitionRx Limited
VNRX
President and CEO
6,780
0.029%
$3.54$24,001+18.08%
2015-05-15PurchaseVolitionRx Limited
VNRX
President and CEO
3,000
0.0159%
$3.33$9,978+8.88%
2014-09-03SaleVolitionRx Limited
VNRX
CEO and President
2.08M
$0$0+92.5%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.